Editor-in-Chief, Therapeutics
Author profile
James M. Wright, MD, PhD, FRCPC
The November 2018 issue of the BCMJ included two articles about diabetes management in British Columbia and a guest editorial that referred to the Therapeutics Initiative (TI). We would like to respond to the... Read More
We thank Dr Kendler for the opportunity to respond to his comments on Therapeutics Letter #108, which summarized Prescrire’s 2017 list of Drugs to Avoid.[1] In letter #108 we explain why we have confidence in the... Read More
We thank Drs Ur and Dawson for their comments on the Therapeutics Letter 68 entitled “Glycemic targets in type 2 diabetes.” We agree with their conclusion that “the precise glucose target has yet to be identified.”... Read More
Drs Miller and Humphries[1] raise important issues regarding serious adverse events (SAEs) that merit further discussion, particularly in relation to our Therapeutics Letter #48, “Do statins have a role... Read More